459 related articles for article (PubMed ID: 7526222)
1. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.
Araki E; Lipes MA; Patti ME; Brüning JC; Haag B; Johnson RS; Kahn CR
Nature; 1994 Nov; 372(6502):186-90. PubMed ID: 7526222
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.
Tamemoto H; Kadowaki T; Tobe K; Yagi T; Sakura H; Hayakawa T; Terauchi Y; Ueki K; Kaburagi Y; Satoh S
Nature; 1994 Nov; 372(6502):182-6. PubMed ID: 7969452
[TBL] [Abstract][Full Text] [Related]
3. Insulin and IGF-I signaling through the insulin receptor substrate 1.
Keller SR; Lamphere L; Lavan BE; Kuhné MR; Lienhard GE
Mol Reprod Dev; 1993 Aug; 35(4):346-51; discussion 351-2. PubMed ID: 8398112
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the actin network in insulin signalling.
Tsakiridis T; Wang Q; Taha C; Grinstein S; Downey G; Klip A
Soc Gen Physiol Ser; 1997; 52():257-71. PubMed ID: 9210235
[TBL] [Abstract][Full Text] [Related]
5. Prolonged vs transient roles for early cell cycle signaling components.
Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
[TBL] [Abstract][Full Text] [Related]
6. ATP-sensitive K+ channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling.
Minami K; Morita M; Saraya A; Yano H; Terauchi Y; Miki T; Kuriyama T; Kadowaki T; Seino S
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1289-96. PubMed ID: 12933351
[TBL] [Abstract][Full Text] [Related]
7. Role of IRS-2 in insulin and cytokine signalling.
Sun XJ; Wang LM; Zhang Y; Yenush L; Myers MG; Glasheen E; Lane WS; Pierce JH; White MF
Nature; 1995 Sep; 377(6545):173-7. PubMed ID: 7675087
[TBL] [Abstract][Full Text] [Related]
8. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
10. The IRS-signalling system in insulin and cytokine action.
White MF
Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):181-9. PubMed ID: 8650265
[TBL] [Abstract][Full Text] [Related]
11. Ethanol impairs insulin receptor substrate-1 mediated signal transduction during rat liver regeneration.
Sasaki Y; Wands JR
Biochem Biophys Res Commun; 1994 Feb; 199(1):403-9. PubMed ID: 7510107
[TBL] [Abstract][Full Text] [Related]
12. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein.
Sun XJ; Rothenberg P; Kahn CR; Backer JM; Araki E; Wilden PA; Cahill DA; Goldstein BJ; White MF
Nature; 1991 Jul; 352(6330):73-7. PubMed ID: 1648180
[TBL] [Abstract][Full Text] [Related]
13. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase.
Myers MG; Sun XJ; Cheatham B; Jachna BR; Glasheen EM; Backer JM; White MF
Endocrinology; 1993 Apr; 132(4):1421-30. PubMed ID: 8384986
[TBL] [Abstract][Full Text] [Related]
14. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
Brüning JC; Winnay J; Cheatham B; Kahn CR
Mol Cell Biol; 1997 Mar; 17(3):1513-21. PubMed ID: 9032279
[TBL] [Abstract][Full Text] [Related]
15. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.
Folli F; Saad MJ; Backer JM; Kahn CR
J Clin Invest; 1993 Oct; 92(4):1787-94. PubMed ID: 7691886
[TBL] [Abstract][Full Text] [Related]
16. Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase.
Rocchi S; Tartare-Deckert S; Mothe I; Van Obberghen E
Endocrinology; 1995 Dec; 136(12):5291-7. PubMed ID: 7588273
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family.
Kaburagi Y; Yamauchi T; Yamamoto-Honda R; Ueki K; Tobe K; Akanuma Y; Yazaki Y; Kadowaki T
Endocr J; 1999 Mar; 46(Suppl):S25-34. PubMed ID: 12054114
[TBL] [Abstract][Full Text] [Related]
18. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice.
Patti ME; Sun XJ; Bruening JC; Araki E; Lipes MA; White MF; Kahn CR
J Biol Chem; 1995 Oct; 270(42):24670-3. PubMed ID: 7559579
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.
Giorgino F; Smith RJ
J Clin Invest; 1995 Sep; 96(3):1473-83. PubMed ID: 7544807
[TBL] [Abstract][Full Text] [Related]
20. Insulin signaling after exercise in insulin receptor substrate-2-deficient mice.
Howlett KF; Sakamoto K; Hirshman MF; Aschenbach WG; Dow M; White MF; Goodyear LJ
Diabetes; 2002 Feb; 51(2):479-83. PubMed ID: 11812758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
